As of 2025-05-24, the Intrinsic Value of Aldeyra Therapeutics Inc (ALDX) is -4.82 USD. This ALDX valuation is based on the model Peter Lynch Fair Value. With the current market price of 2.22 USD, the upside of Aldeyra Therapeutics Inc is -316.95%.
Based on its market price of 2.22 USD and our intrinsic valuation, Aldeyra Therapeutics Inc (ALDX) is overvalued by 316.95%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -4.82 - -4.82 | -4.82 | -316.95% |
| P/E | (10.46) - (17.63) | (13.87) | -724.8% |
| DDM - Stable | (7.81) - (26.46) | (17.14) | -871.9% |
| DDM - Multi | (6.15) - (16.67) | (9.04) | -507.2% |
| Market Cap (mil) | 132.98 |
| Beta | 2.48 |
| Outstanding shares (mil) | 59.90 |
| Enterprise Value (mil) | 97.73 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.95% |
| Cost of Debt | 5.00% |
| WACC | 9.31% |